General Info

Founded in 1981, Arrhythmia Research Technology produces signal-averaged electrocardiography products, which are used for the detection of cardiac late potentials. The company s products are used by major research institutions, hospitals and clinics throughout the world. The company s signal-averaging and hemodynamics technologies are designed to assist physicians in detecting and treating electrical and physical malfunctions of the heart. In addition, the company s MICRON Products subsidiary manufactures silver and silver chloride-plated electrode sensor components for electrocardiography. Arrhythmia Research Technology is a publicly traded company. Its shares are listed on the American Stock exchange under the symbol HRT. The company is headquartered in Fitchburg, Mass.